Genflow Biosciences to Attend BIO San Diego as Chairman Gad Berdugo Joins mRNA Panel

GENF

Genflow Biosciences plc (LON:GENF) will be present at BIO San Diego, which takes place from June 22 to June 25.

The London-listed biotechnology company, will attend the industry event in San Diego as part of its engagement with the wider life sciences and biotechnology community.

Genflow Bio chairman Gad Berdugo will also participate in an mRNA panel during the event. The panel is scheduled for Tuesday, June 23, from 7:30am to 9:00am Pacific Time, at Garibaldi, 901 Bayfront Ct Ste 1, San Diego, CA 92101.

The session is connected with the Alliance for mRNA Medicines, which brings together researchers and industry leaders working to advance mRNA research and support the development of new medicines for patients with serious diseases and unmet medical needs.

Genflow’s presence at BIO San Diego and Berdugo’s participation in the mRNA panel will place the company in discussions linked to biotechnology, therapeutic innovation and the development of new approaches in medicine.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Genflow Biosciences reports early findings from SIRT6 gene therapy study

Genflow Biosciences reports early findings from its SIRT6 gene therapy study in older dogs, with further monitoring planned over...

Genflow Biosciences targets canine longevity as interest in pet ageing treatments grows

Genflow Biosciences is developing SIRT6 gene therapy aimed at improving canine longevity and reducing age-related muscle loss, as interest...

Biotech companies target longer lifespans for dogs and cats through gene therapy

Biotechnology companies are developing gene therapies and anti-ageing drugs for dogs and cats, targeting age-related diseases and the potential...

Genflow Biosciences in focus as longevity research expands into animal health

Longevity research is expanding into animal health, while Genflow Biosciences continues to focus on the potential of SIRT6-related science...

Pet food industry turns to healthy ageing as demand for longevity products grows

Growing interest in pet longevity is creating opportunities for specialised nutrition, supplements and veterinary treatments. Improved research into the...

Genflow Biosciences CEO Dr Eric Leire discusses SIRT6 gene therapy results in aged dogs

Genflow Biosciences CEO Dr Eric Leire discusses interim SLAB-VET trial results, the potential of SIRT6 gene therapy in ageing...

Search